📌 Key Takeaways
- Topic: Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
- Keywords: Cab-O-Sil M-5
- Published: 2026-11-20 05:34:52
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Cristobalite? Properties, Uses and How It Differs from Quartz
- High Purity Quartz Sand: Specifications, Uses in Solar and Semiconductors, and Suppliers
- What Is Silica Powder? Types, Particle Sizes, Grades and Common Applications
- Luo, Z. et al. Mesoporous silica nanoparticles end‐capped with collagen: redox‐responsive nanoreservoirs for targeted drug delivery. Angew. Chem. Int. Ed. 50, 640-643 (2011). Article CAS Google Scholar
- 325 Mesh Silica: Particle Size, Specifications and Common Applications
- Silica as an Adsorbent: How It Works and Common Applications
- Sakamoto, Y. et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature 408, 449-453 (2000). Post CAS PubMed Google Scholar
Alumina Powder vs Silica Powder: Properties, Uses and How to Choose
What is silica (SiO₂)?
monodisperse silica spheres The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
What is the difference between fumed silica and precipitated silica?
anti caking agent silica
What drives silica raw material prices?
silica industry outlook
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.